Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
38.9M
-
Shares change
-
+1.6M
-
Total reported value, excl. options
-
$280M
-
Value change
-
+$12M
-
Put/Call ratio
-
0.65
-
Number of buys
-
46
-
Number of sells
-
-20
-
Price
-
$7.20
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q2 2023
84 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q2 2023.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.9M shares
of 240M outstanding shares and own 16.17% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.4M shares), Phoenix Holdings Ltd. (6.35M shares), CROSSLINK CAPITAL INC (3.21M shares), Isomer Partners LP (2.19M shares), MORGAN STANLEY (2.16M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (2.12M shares), Northern Right Capital Management, L.P. (1.23M shares), ROYCE & ASSOCIATES LP (761K shares), MAKENA CAPITAL MANAGEMENT LLC (650K shares), and BlackRock Inc. (477K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.